Name | Meisoindigo |
Synonyms | Dian III Natura-α Meisoindigo MEISOINDIGO Methylisoindigotin N-methylisoindigotin 1-METHYL-3,3'-BIINDOLE-2,2'(1H,1'H)-DIONE 3-(1,2-dihydro-2-oxo-3h-indol-3-ylidene)-1,3-dihydro-1-methyl-2h-indol-2-one Meisoindigo 3-(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)-1,3-dihydro-1-methyl-2H-indol-2-one |
CAS | 97207-47-1 |
EINECS | 200-256-5 |
Molecular Formula | C17H12N2O2 |
Molar Mass | 276.29 |
Melting Point | 236-237°C |
Appearance | powder to crystal |
Color | Orange to Brown to Dark red |
Storage Condition | Sealed in dry,Room Temperature |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.619 ml | 18.097 ml | 36.194 ml |
5 mM | 0.724 ml | 3.619 ml | 7.239 ml |
10 mM | 0.362 ml | 1.81 ml | 3.619 ml |
5 mM | 0.072 ml | 0.362 ml | 0.724 ml |
biological activity | Meisoindigo (Dian III) is a derivative of Indirubin (HY-N0117), can cause acute myeloid leukemia (AML) cell cycle arrest in G0/G1 phase, and induce apoptosis. Meisoindigo has high anti-tumor activity. |
Cell Line: | HL-60, NB4, U937 leukemic cell lines HL-60 cells HL-60 cells HL-60 cells |
Concentration: | 5, 10, 15, 20 μM 10 μM 5, 10 μM 5, 10 μM |
Incubation Time: | For 24 hours For 24 hours For 24 hours For 24 hours |
Result: | Inhibited growth of the AML cell lines in a dose- and time-dependent manner. Induced apoptosis of acute myeloid leukemia. Caused cell-cycle arrest, with more cells in sub-G1 and G0/G1 phases and fewer cells in the S phase, in a dose-dependent manner. Increased the cleaved caspase-3 and pro-apoptotic Bak, and decreased Bcl-2 and Bcl-xL levels in HL-60 cells. Had anti-leukemic activity in vivo. |
Animal Model: | NOD/SCID mice, 6-8 weeks old, with HL-60 leukemic cells |
Dosage: | 50, 100, 150 mg/kg |
Administration: | IP; daily; for 14 days |